Abpro Bio Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 8 million compared to negative sales of KRW 0.00034 million a year ago. Net loss was KRW 4,012.82 million compared to KRW 1,682 million a year ago.
Basic loss per share from continuing operations was KRW 14.66 compared to KRW 6.46 a year ago. Basic loss per share was KRW 14.66 compared to KRW 6.46 a year ago.